Quantcast

Latest Pemetrexed Stories

2011-10-17 12:57:42

Lung cancer patients with diabetes tend to live longer than patients without diabetes, according to a Norwegian study published in the November issue of the Journal of Thoracic Oncology, the official publication of the International Association for the Study of Lung Cancer. Researchers did not speculate on the reason for the effect, but said that the survival benefit warranted more study and that diabetes should not be considered a reason to withhold standard cancer treatment. "Standard...

2011-09-10 10:00:00

The Mesothelioma Applied Research Foundation reminds the public that 400,000 tons of asbestos were released in the air of Manhattan on September 11, 2001, making thousands of people at risk for the mesothelioma cancer. Washington, DC (PRWEB) September 10, 2011 On this September 11th, many will mourn, in public or privately, the loss of more than 2,500 lives in New York on 9/11/01. The Mesothelioma Applied Research Foundation acknowledges that few may be aware, however, that those who were...

2011-09-01 12:54:27

Patients with ALK-rearranged non-small cell lung cancer (NSCLC) responded significantly better to pemetrexed (brand name: Alimta) than patients whose cancer did not show ALK translocation, according to research published in the September issue of the Journal of Thoracic Oncology, the official publication of the International Association for the Study of Lung Cancer (IASLC). Lung adenocarcinoma can display genetic mutations, including anaplastic lymphoma kinase (ALK) rearrangement and...

2011-07-13 07:20:00

INDIANAPOLIS, July 13, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced that it has made a charitable contribution to the Patient Advocate Foundation (PAF). The donation will enable expansion of the foundation's patient services programs, including Case Management and Co-Pay Relief (CPR) Programs in support of a new fund for patients with nonsquamous non-small cell lung cancer (NSCLC), the most common form of lung cancer. PAF is a national, non-profit organization that...

2011-06-06 17:30:00

CHICAGO and SAN DIEGO, June 6, 2011 /PRNewswire/ -- Tragara Pharmaceuticals, Inc. announced today that apricoxib (Capoxigem®, TG01) in combination with erlotinib demonstrated significant and consistent clinical benefit over erlotinib alone in a clinically relevant subset of biomarker-selected patients with non-small cell lung cancer (NSCLC) who had previously failed a platinum-containing regimen for advanced disease. Complete data from the study, APRiCOT-L, were...

2011-06-05 08:00:00

INDIANAPOLIS, June 5, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that PARAMOUNT, its Phase III study evaluating ALIMTA® (pemetrexed for injection) in the continuation maintenance setting, met its primary endpoint of progression-free survival, or the time a patient is alive without their disease worsening, for patients with a specific type of lung cancer called advanced nonsquamous non-small cell lung cancer (NSCLC). "Continuation maintenance"...


Word of the Day
lunula
  • A small crescent-shaped structure or marking, especially the white area at the base of a fingernail that resembles a half-moon.
This word is a diminutive of the Latin 'luna,' moon.
Related